Protagenic Therapeutics Inc. (PTIX) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	10.39M
Investments	1.46M
Accounts receivable, net
Inventories	2.32M
Prepaid expenses and other assets
Prepaid income taxes	146K
Fair value of foreign currency hedge contracts
Total current assets	21.42M
Investments
Property, equipment and improvements, net
Software development costs, net	3.54M
Purchased intangible assets, net	2.13M
Total assets	30.95M
Accounts payable	1.33M
Other payable
Deferred revenue
Accrued expenses	1.5M
Total current liabilities	5.26M
Deferred income taxes
Total liabilities	5.92M
Preferred stock value
Common stock shares outstanding
Common stock - $.01 par value: 50,000,000 shares authorized; 13,304,596 shares issued
Additional paid-in capital
Retained earnings	16.76M
Accumulated other comprehensive income	-7K
Treasury stock - at cost; 2,188,199 shares
Total stockholders’ equity	25.03M
Total liabilities and stockholders’ equity	30.95M

Entities mentioned with PTIX

View All Entities